Addgene: mTOR_2 shRNA Citations

mTOR_2 shRNA Citations (13)

Originally described in: Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.
Sarbassov DD, Guertin DA, Ali SM, Sabatini DM Science 2005 Feb 18;307(5712):1098-101. PubMed Journal

Articles Citing mTOR_2 shRNA

Showing 1 to 10 of 13 entries

Show entries

Search table:

Articles
An Excitable Ras/PI3K/ERK Signaling Network Controls Migration and Oncogenic Transformation in Epithelial Cells. Zhan H, Bhattacharya S, Cai H, Iglesias PA, Huang CH, Devreotes PN. Dev Cell. 2020 Sep 14;54(5):608-623.e5. doi: 10.1016/j.devcel.2020.08.001. Epub 2020 Sep 1. PubMed
The mTOR cell signaling pathway is crucial to the long-term protective effects of ischemic postconditioning against stroke. Wang P, Xie R, Cheng M, Sapolsky R, Ji X, Zhao H. Neurosci Lett. 2018 May 29;676:58-65. doi: 10.1016/j.neulet.2018.03.062. Epub 2018 Mar 29. PubMed
Specific inhibition of mTOR pathway induces anti-proliferative effect and decreases the hormone secretion in cultured pituitary adenoma cells. Xie R, He WQ, Shen M, Shou XF, Wang YF, Bao WM, Zhao Y. J Neurooncol. 2015 Oct;125(1):79-89. doi: 10.1007/s11060-015-1895-x. Epub 2015 Aug 22. PubMed
Splicing of a non-coding antisense transcript controls LEF1 gene expression. Beltran M, Aparicio-Prat E, Mazzolini R, Millanes-Romero A, Masso P, Jenner RG, Diaz VM, Peiro S, de Herreros AG. Nucleic Acids Res. 2015 Jul 13;43(12):5785-97. doi: 10.1093/nar/gkv502. Epub 2015 May 18. PubMed
Rapamycin antagonizes TNF induction of VCAM-1 on endothelial cells by inhibiting mTORC2. Wang C, Qin L, Manes TD, Kirkiles-Smith NC, Tellides G, Pober JS. J Exp Med. 2014 Mar 10;211(3):395-404. doi: 10.1084/jem.20131125. Epub 2014 Feb 10. PubMed
mTOR regulates phagosome and entotic vacuole fission. Krajcovic M, Krishna S, Akkari L, Joyce JA, Overholtzer M. Mol Biol Cell. 2013 Dec;24(23):3736-45. doi: 10.1091/mbc.E13-07-0408. Epub 2013 Oct 2. PubMed
Genetic and pharmacologic inhibition of mTORC1 promotes EMT by a TGF-beta-independent mechanism. Mikaelian I, Malek M, Gadet R, Viallet J, Garcia A, Girard-Gagnepain A, Hesling C, Gillet G, Gonzalo P, Rimokh R, Billaud M. Cancer Res. 2013 Nov 15;73(22):6621-31. doi: 10.1158/0008-5472.CAN-13-0560. Epub 2013 Sep 27. PubMed
Mammalian target of rapamycin (mTor) mediates tau protein dyshomeostasis: implication for Alzheimer disease. Tang Z, Bereczki E, Zhang H, Wang S, Li C, Ji X, Branca RM, Lehtio J, Guan Z, Filipcik P, Xu S, Winblad B, Pei JJ. J Biol Chem. 2013 May 31;288(22):15556-70. doi: 10.1074/jbc.M112.435123. Epub 2013 Apr 12. PubMed
Rapamycin-treated human endothelial cells preferentially activate allogeneic regulatory T cells. Wang C, Yi T, Qin L, Maldonado RA, von Andrian UH, Kulkarni S, Tellides G, Pober JS. J Clin Invest. 2013 Apr;123(4):1677-93. doi: 10.1172/JCI66204. Epub 2013 Mar 8. PubMed
Epigallocatechin-3-gallate diminishes cytokine-stimulated Cyr61 expression in human osteoblastic cells: a therapeutic potential for arthritis. Wu PH, Lin SK, Lee BS, Kok SH, Wang JH, Hou KL, Yang H, Lai EH, Wang JS, Hong CY. Rheumatology (Oxford). 2012 Nov;51(11):1953-65. doi: 10.1093/rheumatology/kes174. Epub 2012 Jul 28. PubMed

If you have published an article using this material, please email us at help@addgene.org to have your article added to this page.